Pharma & Healthcare
Global Enzalutamide Drugs Market Research Report 2024
- Sep 18, 24
- ID: 553566
- Pages: 105
- Figures: 106
- Views: 1
Enzalutamide drugs are medications that contain enzalutamide, an androgen receptor inhibitor that works by blocking the effects of androgens (male hormones like testosterone) on cancer cells.
The global Enzalutamide Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Enzalutamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enzalutamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enzalutamide Drugs include Astellas Pharma, Pfizer, Intas Pharmaceuticals, Beacon pharma, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, Sun Pharma, Zydus, Abbott Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enzalutamide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzalutamide Drugs.
The Enzalutamide Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enzalutamide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enzalutamide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Astellas Pharma
Pfizer
Intas Pharmaceuticals
Beacon pharma
Aprazer Healthcare Pharma
Arechar Healthcare
Glenmark Pharma
Sun Pharma
Zydus
Abbott Laboratories
BDR Pharma
Qilu Pharmaceutical
Kelun Pharmaceutical
Yichang Humanwell Pharmaceutical
Jiangsu Hansoh Pharmaceutical
PuraCap Pharmaceuticals
Shenyang Hongqi Pharmaceutical
Segment by Type
Tablets
Capsules
Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enzalutamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enzalutamide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Enzalutamide Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Enzalutamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Enzalutamide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Enzalutamide Drugs include Astellas Pharma, Pfizer, Intas Pharmaceuticals, Beacon pharma, Aprazer Healthcare Pharma, Arechar Healthcare, Glenmark Pharma, Sun Pharma, Zydus, Abbott Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Enzalutamide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzalutamide Drugs.
The Enzalutamide Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Enzalutamide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enzalutamide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Astellas Pharma
Pfizer
Intas Pharmaceuticals
Beacon pharma
Aprazer Healthcare Pharma
Arechar Healthcare
Glenmark Pharma
Sun Pharma
Zydus
Abbott Laboratories
BDR Pharma
Qilu Pharmaceutical
Kelun Pharmaceutical
Yichang Humanwell Pharmaceutical
Jiangsu Hansoh Pharmaceutical
PuraCap Pharmaceuticals
Shenyang Hongqi Pharmaceutical
Segment by Type
Tablets
Capsules
Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enzalutamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enzalutamide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Enzalutamide Drugs Market Overview
1.1 Product Definition
1.2 Enzalutamide Drugs by Type
1.2.1 Global Enzalutamide Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.3 Enzalutamide Drugs by Application
1.3.1 Global Enzalutamide Drugs Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Enzalutamide Drugs Market Size Estimates and Forecasts
1.4.1 Global Enzalutamide Drugs Revenue 2019-2030
1.4.2 Global Enzalutamide Drugs Sales 2019-2030
1.4.3 Global Enzalutamide Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enzalutamide Drugs Market Competition by Manufacturers
2.1 Global Enzalutamide Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enzalutamide Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enzalutamide Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Enzalutamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enzalutamide Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enzalutamide Drugs, Product Type & Application
2.7 Global Key Manufacturers of Enzalutamide Drugs, Date of Enter into This Industry
2.8 Global Enzalutamide Drugs Market Competitive Situation and Trends
2.8.1 Global Enzalutamide Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enzalutamide Drugs Players Market Share by Revenue
2.8.3 Global Enzalutamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enzalutamide Drugs Market Scenario by Region
3.1 Global Enzalutamide Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enzalutamide Drugs Sales by Region: 2019-2030
3.2.1 Global Enzalutamide Drugs Sales by Region: 2019-2024
3.2.2 Global Enzalutamide Drugs Sales by Region: 2025-2030
3.3 Global Enzalutamide Drugs Revenue by Region: 2019-2030
3.3.1 Global Enzalutamide Drugs Revenue by Region: 2019-2024
3.3.2 Global Enzalutamide Drugs Revenue by Region: 2025-2030
3.4 North America Enzalutamide Drugs Market Facts & Figures by Country
3.4.1 North America Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enzalutamide Drugs Sales by Country (2019-2030)
3.4.3 North America Enzalutamide Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enzalutamide Drugs Market Facts & Figures by Country
3.5.1 Europe Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enzalutamide Drugs Sales by Country (2019-2030)
3.5.3 Europe Enzalutamide Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enzalutamide Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Enzalutamide Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enzalutamide Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Enzalutamide Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Enzalutamide Drugs Market Facts & Figures by Country
3.7.1 Latin America Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enzalutamide Drugs Sales by Country (2019-2030)
3.7.3 Latin America Enzalutamide Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Enzalutamide Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enzalutamide Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enzalutamide Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enzalutamide Drugs Sales by Type (2019-2030)
4.1.1 Global Enzalutamide Drugs Sales by Type (2019-2024)
4.1.2 Global Enzalutamide Drugs Sales by Type (2025-2030)
4.1.3 Global Enzalutamide Drugs Sales Market Share by Type (2019-2030)
4.2 Global Enzalutamide Drugs Revenue by Type (2019-2030)
4.2.1 Global Enzalutamide Drugs Revenue by Type (2019-2024)
4.2.2 Global Enzalutamide Drugs Revenue by Type (2025-2030)
4.2.3 Global Enzalutamide Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Enzalutamide Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enzalutamide Drugs Sales by Application (2019-2030)
5.1.1 Global Enzalutamide Drugs Sales by Application (2019-2024)
5.1.2 Global Enzalutamide Drugs Sales by Application (2025-2030)
5.1.3 Global Enzalutamide Drugs Sales Market Share by Application (2019-2030)
5.2 Global Enzalutamide Drugs Revenue by Application (2019-2030)
5.2.1 Global Enzalutamide Drugs Revenue by Application (2019-2024)
5.2.2 Global Enzalutamide Drugs Revenue by Application (2025-2030)
5.2.3 Global Enzalutamide Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Enzalutamide Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma
6.1.1 Astellas Pharma Company Information
6.1.2 Astellas Pharma Description and Business Overview
6.1.3 Astellas Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma Enzalutamide Drugs Product Portfolio
6.1.5 Astellas Pharma Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Enzalutamide Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Intas Pharmaceuticals
6.3.1 Intas Pharmaceuticals Company Information
6.3.2 Intas Pharmaceuticals Description and Business Overview
6.3.3 Intas Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Intas Pharmaceuticals Enzalutamide Drugs Product Portfolio
6.3.5 Intas Pharmaceuticals Recent Developments/Updates
6.4 Beacon pharma
6.4.1 Beacon pharma Company Information
6.4.2 Beacon pharma Description and Business Overview
6.4.3 Beacon pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beacon pharma Enzalutamide Drugs Product Portfolio
6.4.5 Beacon pharma Recent Developments/Updates
6.5 Aprazer Healthcare Pharma
6.5.1 Aprazer Healthcare Pharma Company Information
6.5.2 Aprazer Healthcare Pharma Description and Business Overview
6.5.3 Aprazer Healthcare Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolio
6.5.5 Aprazer Healthcare Pharma Recent Developments/Updates
6.6 Arechar Healthcare
6.6.1 Arechar Healthcare Company Information
6.6.2 Arechar Healthcare Description and Business Overview
6.6.3 Arechar Healthcare Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Arechar Healthcare Enzalutamide Drugs Product Portfolio
6.6.5 Arechar Healthcare Recent Developments/Updates
6.7 Glenmark Pharma
6.7.1 Glenmark Pharma Company Information
6.7.2 Glenmark Pharma Description and Business Overview
6.7.3 Glenmark Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Glenmark Pharma Enzalutamide Drugs Product Portfolio
6.7.5 Glenmark Pharma Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharma Enzalutamide Drugs Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Zydus
6.9.1 Zydus Company Information
6.9.2 Zydus Description and Business Overview
6.9.3 Zydus Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zydus Enzalutamide Drugs Product Portfolio
6.9.5 Zydus Recent Developments/Updates
6.10 Abbott Laboratories
6.10.1 Abbott Laboratories Company Information
6.10.2 Abbott Laboratories Description and Business Overview
6.10.3 Abbott Laboratories Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abbott Laboratories Enzalutamide Drugs Product Portfolio
6.10.5 Abbott Laboratories Recent Developments/Updates
6.11 BDR Pharma
6.11.1 BDR Pharma Company Information
6.11.2 BDR Pharma Description and Business Overview
6.11.3 BDR Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BDR Pharma Enzalutamide Drugs Product Portfolio
6.11.5 BDR Pharma Recent Developments/Updates
6.12 Qilu Pharmaceutical
6.12.1 Qilu Pharmaceutical Company Information
6.12.2 Qilu Pharmaceutical Description and Business Overview
6.12.3 Qilu Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Qilu Pharmaceutical Enzalutamide Drugs Product Portfolio
6.12.5 Qilu Pharmaceutical Recent Developments/Updates
6.13 Kelun Pharmaceutical
6.13.1 Kelun Pharmaceutical Company Information
6.13.2 Kelun Pharmaceutical Description and Business Overview
6.13.3 Kelun Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Kelun Pharmaceutical Enzalutamide Drugs Product Portfolio
6.13.5 Kelun Pharmaceutical Recent Developments/Updates
6.14 Yichang Humanwell Pharmaceutical
6.14.1 Yichang Humanwell Pharmaceutical Company Information
6.14.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.14.3 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolio
6.14.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
6.15 Jiangsu Hansoh Pharmaceutical
6.15.1 Jiangsu Hansoh Pharmaceutical Company Information
6.15.2 Jiangsu Hansoh Pharmaceutical Description and Business Overview
6.15.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolio
6.15.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.16 PuraCap Pharmaceuticals
6.16.1 PuraCap Pharmaceuticals Company Information
6.16.2 PuraCap Pharmaceuticals Description and Business Overview
6.16.3 PuraCap Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolio
6.16.5 PuraCap Pharmaceuticals Recent Developments/Updates
6.17 Shenyang Hongqi Pharmaceutical
6.17.1 Shenyang Hongqi Pharmaceutical Company Information
6.17.2 Shenyang Hongqi Pharmaceutical Description and Business Overview
6.17.3 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolio
6.17.5 Shenyang Hongqi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enzalutamide Drugs Industry Chain Analysis
7.2 Enzalutamide Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enzalutamide Drugs Production Mode & Process
7.4 Enzalutamide Drugs Sales and Marketing
7.4.1 Enzalutamide Drugs Sales Channels
7.4.2 Enzalutamide Drugs Distributors
7.5 Enzalutamide Drugs Customers
8 Enzalutamide Drugs Market Dynamics
8.1 Enzalutamide Drugs Industry Trends
8.2 Enzalutamide Drugs Market Drivers
8.3 Enzalutamide Drugs Market Challenges
8.4 Enzalutamide Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Enzalutamide Drugs by Type
1.2.1 Global Enzalutamide Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.3 Enzalutamide Drugs by Application
1.3.1 Global Enzalutamide Drugs Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Global Enzalutamide Drugs Market Size Estimates and Forecasts
1.4.1 Global Enzalutamide Drugs Revenue 2019-2030
1.4.2 Global Enzalutamide Drugs Sales 2019-2030
1.4.3 Global Enzalutamide Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enzalutamide Drugs Market Competition by Manufacturers
2.1 Global Enzalutamide Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enzalutamide Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enzalutamide Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Enzalutamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enzalutamide Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enzalutamide Drugs, Product Type & Application
2.7 Global Key Manufacturers of Enzalutamide Drugs, Date of Enter into This Industry
2.8 Global Enzalutamide Drugs Market Competitive Situation and Trends
2.8.1 Global Enzalutamide Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Enzalutamide Drugs Players Market Share by Revenue
2.8.3 Global Enzalutamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Enzalutamide Drugs Market Scenario by Region
3.1 Global Enzalutamide Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enzalutamide Drugs Sales by Region: 2019-2030
3.2.1 Global Enzalutamide Drugs Sales by Region: 2019-2024
3.2.2 Global Enzalutamide Drugs Sales by Region: 2025-2030
3.3 Global Enzalutamide Drugs Revenue by Region: 2019-2030
3.3.1 Global Enzalutamide Drugs Revenue by Region: 2019-2024
3.3.2 Global Enzalutamide Drugs Revenue by Region: 2025-2030
3.4 North America Enzalutamide Drugs Market Facts & Figures by Country
3.4.1 North America Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enzalutamide Drugs Sales by Country (2019-2030)
3.4.3 North America Enzalutamide Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enzalutamide Drugs Market Facts & Figures by Country
3.5.1 Europe Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enzalutamide Drugs Sales by Country (2019-2030)
3.5.3 Europe Enzalutamide Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enzalutamide Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Enzalutamide Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enzalutamide Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Enzalutamide Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Enzalutamide Drugs Market Facts & Figures by Country
3.7.1 Latin America Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enzalutamide Drugs Sales by Country (2019-2030)
3.7.3 Latin America Enzalutamide Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Enzalutamide Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Enzalutamide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enzalutamide Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enzalutamide Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enzalutamide Drugs Sales by Type (2019-2030)
4.1.1 Global Enzalutamide Drugs Sales by Type (2019-2024)
4.1.2 Global Enzalutamide Drugs Sales by Type (2025-2030)
4.1.3 Global Enzalutamide Drugs Sales Market Share by Type (2019-2030)
4.2 Global Enzalutamide Drugs Revenue by Type (2019-2030)
4.2.1 Global Enzalutamide Drugs Revenue by Type (2019-2024)
4.2.2 Global Enzalutamide Drugs Revenue by Type (2025-2030)
4.2.3 Global Enzalutamide Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Enzalutamide Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enzalutamide Drugs Sales by Application (2019-2030)
5.1.1 Global Enzalutamide Drugs Sales by Application (2019-2024)
5.1.2 Global Enzalutamide Drugs Sales by Application (2025-2030)
5.1.3 Global Enzalutamide Drugs Sales Market Share by Application (2019-2030)
5.2 Global Enzalutamide Drugs Revenue by Application (2019-2030)
5.2.1 Global Enzalutamide Drugs Revenue by Application (2019-2024)
5.2.2 Global Enzalutamide Drugs Revenue by Application (2025-2030)
5.2.3 Global Enzalutamide Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Enzalutamide Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma
6.1.1 Astellas Pharma Company Information
6.1.2 Astellas Pharma Description and Business Overview
6.1.3 Astellas Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma Enzalutamide Drugs Product Portfolio
6.1.5 Astellas Pharma Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Enzalutamide Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Intas Pharmaceuticals
6.3.1 Intas Pharmaceuticals Company Information
6.3.2 Intas Pharmaceuticals Description and Business Overview
6.3.3 Intas Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Intas Pharmaceuticals Enzalutamide Drugs Product Portfolio
6.3.5 Intas Pharmaceuticals Recent Developments/Updates
6.4 Beacon pharma
6.4.1 Beacon pharma Company Information
6.4.2 Beacon pharma Description and Business Overview
6.4.3 Beacon pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beacon pharma Enzalutamide Drugs Product Portfolio
6.4.5 Beacon pharma Recent Developments/Updates
6.5 Aprazer Healthcare Pharma
6.5.1 Aprazer Healthcare Pharma Company Information
6.5.2 Aprazer Healthcare Pharma Description and Business Overview
6.5.3 Aprazer Healthcare Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aprazer Healthcare Pharma Enzalutamide Drugs Product Portfolio
6.5.5 Aprazer Healthcare Pharma Recent Developments/Updates
6.6 Arechar Healthcare
6.6.1 Arechar Healthcare Company Information
6.6.2 Arechar Healthcare Description and Business Overview
6.6.3 Arechar Healthcare Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Arechar Healthcare Enzalutamide Drugs Product Portfolio
6.6.5 Arechar Healthcare Recent Developments/Updates
6.7 Glenmark Pharma
6.7.1 Glenmark Pharma Company Information
6.7.2 Glenmark Pharma Description and Business Overview
6.7.3 Glenmark Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Glenmark Pharma Enzalutamide Drugs Product Portfolio
6.7.5 Glenmark Pharma Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharma Enzalutamide Drugs Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Zydus
6.9.1 Zydus Company Information
6.9.2 Zydus Description and Business Overview
6.9.3 Zydus Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zydus Enzalutamide Drugs Product Portfolio
6.9.5 Zydus Recent Developments/Updates
6.10 Abbott Laboratories
6.10.1 Abbott Laboratories Company Information
6.10.2 Abbott Laboratories Description and Business Overview
6.10.3 Abbott Laboratories Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abbott Laboratories Enzalutamide Drugs Product Portfolio
6.10.5 Abbott Laboratories Recent Developments/Updates
6.11 BDR Pharma
6.11.1 BDR Pharma Company Information
6.11.2 BDR Pharma Description and Business Overview
6.11.3 BDR Pharma Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 BDR Pharma Enzalutamide Drugs Product Portfolio
6.11.5 BDR Pharma Recent Developments/Updates
6.12 Qilu Pharmaceutical
6.12.1 Qilu Pharmaceutical Company Information
6.12.2 Qilu Pharmaceutical Description and Business Overview
6.12.3 Qilu Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Qilu Pharmaceutical Enzalutamide Drugs Product Portfolio
6.12.5 Qilu Pharmaceutical Recent Developments/Updates
6.13 Kelun Pharmaceutical
6.13.1 Kelun Pharmaceutical Company Information
6.13.2 Kelun Pharmaceutical Description and Business Overview
6.13.3 Kelun Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Kelun Pharmaceutical Enzalutamide Drugs Product Portfolio
6.13.5 Kelun Pharmaceutical Recent Developments/Updates
6.14 Yichang Humanwell Pharmaceutical
6.14.1 Yichang Humanwell Pharmaceutical Company Information
6.14.2 Yichang Humanwell Pharmaceutical Description and Business Overview
6.14.3 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product Portfolio
6.14.5 Yichang Humanwell Pharmaceutical Recent Developments/Updates
6.15 Jiangsu Hansoh Pharmaceutical
6.15.1 Jiangsu Hansoh Pharmaceutical Company Information
6.15.2 Jiangsu Hansoh Pharmaceutical Description and Business Overview
6.15.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product Portfolio
6.15.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.16 PuraCap Pharmaceuticals
6.16.1 PuraCap Pharmaceuticals Company Information
6.16.2 PuraCap Pharmaceuticals Description and Business Overview
6.16.3 PuraCap Pharmaceuticals Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 PuraCap Pharmaceuticals Enzalutamide Drugs Product Portfolio
6.16.5 PuraCap Pharmaceuticals Recent Developments/Updates
6.17 Shenyang Hongqi Pharmaceutical
6.17.1 Shenyang Hongqi Pharmaceutical Company Information
6.17.2 Shenyang Hongqi Pharmaceutical Description and Business Overview
6.17.3 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product Portfolio
6.17.5 Shenyang Hongqi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enzalutamide Drugs Industry Chain Analysis
7.2 Enzalutamide Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enzalutamide Drugs Production Mode & Process
7.4 Enzalutamide Drugs Sales and Marketing
7.4.1 Enzalutamide Drugs Sales Channels
7.4.2 Enzalutamide Drugs Distributors
7.5 Enzalutamide Drugs Customers
8 Enzalutamide Drugs Market Dynamics
8.1 Enzalutamide Drugs Industry Trends
8.2 Enzalutamide Drugs Market Drivers
8.3 Enzalutamide Drugs Market Challenges
8.4 Enzalutamide Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Enzalutamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Enzalutamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Enzalutamide Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Enzalutamide Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Enzalutamide Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Enzalutamide Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Enzalutamide Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Enzalutamide Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Enzalutamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enzalutamide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enzalutamide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Enzalutamide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enzalutamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enzalutamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Enzalutamide Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Enzalutamide Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Enzalutamide Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Enzalutamide Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Enzalutamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Enzalutamide Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Enzalutamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Enzalutamide Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Enzalutamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Enzalutamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Enzalutamide Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Enzalutamide Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Enzalutamide Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Enzalutamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Enzalutamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Enzalutamide Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Enzalutamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Enzalutamide Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Enzalutamide Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Enzalutamide Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Enzalutamide Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Enzalutamide Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Enzalutamide Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Enzalutamide Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Enzalutamide Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Enzalutamide Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Enzalutamide Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Enzalutamide Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Enzalutamide Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Enzalutamide Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Enzalutamide Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Enzalutamide Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Enzalutamide Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Enzalutamide Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Enzalutamide Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Enzalutamide Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Enzalutamide Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Astellas Pharma Company Information
Table 71. Astellas Pharma Description and Business Overview
Table 72. Astellas Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Astellas Pharma Enzalutamide Drugs Product
Table 74. Astellas Pharma Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Enzalutamide Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Intas Pharmaceuticals Company Information
Table 81. Intas Pharmaceuticals Description and Business Overview
Table 82. Intas Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Intas Pharmaceuticals Enzalutamide Drugs Product
Table 84. Intas Pharmaceuticals Recent Developments/Updates
Table 85. Beacon pharma Company Information
Table 86. Beacon pharma Description and Business Overview
Table 87. Beacon pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Beacon pharma Enzalutamide Drugs Product
Table 89. Beacon pharma Recent Developments/Updates
Table 90. Aprazer Healthcare Pharma Company Information
Table 91. Aprazer Healthcare Pharma Description and Business Overview
Table 92. Aprazer Healthcare Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Aprazer Healthcare Pharma Enzalutamide Drugs Product
Table 94. Aprazer Healthcare Pharma Recent Developments/Updates
Table 95. Arechar Healthcare Company Information
Table 96. Arechar Healthcare Description and Business Overview
Table 97. Arechar Healthcare Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Arechar Healthcare Enzalutamide Drugs Product
Table 99. Arechar Healthcare Recent Developments/Updates
Table 100. Glenmark Pharma Company Information
Table 101. Glenmark Pharma Description and Business Overview
Table 102. Glenmark Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Glenmark Pharma Enzalutamide Drugs Product
Table 104. Glenmark Pharma Recent Developments/Updates
Table 105. Sun Pharma Company Information
Table 106. Sun Pharma Description and Business Overview
Table 107. Sun Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sun Pharma Enzalutamide Drugs Product
Table 109. Sun Pharma Recent Developments/Updates
Table 110. Zydus Company Information
Table 111. Zydus Description and Business Overview
Table 112. Zydus Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zydus Enzalutamide Drugs Product
Table 114. Zydus Recent Developments/Updates
Table 115. Abbott Laboratories Company Information
Table 116. Abbott Laboratories Description and Business Overview
Table 117. Abbott Laboratories Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Abbott Laboratories Enzalutamide Drugs Product
Table 119. Abbott Laboratories Recent Developments/Updates
Table 120. BDR Pharma Company Information
Table 121. BDR Pharma Description and Business Overview
Table 122. BDR Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. BDR Pharma Enzalutamide Drugs Product
Table 124. BDR Pharma Recent Developments/Updates
Table 125. Qilu Pharmaceutical Company Information
Table 126. Qilu Pharmaceutical Description and Business Overview
Table 127. Qilu Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Qilu Pharmaceutical Enzalutamide Drugs Product
Table 129. Qilu Pharmaceutical Recent Developments/Updates
Table 130. Kelun Pharmaceutical Company Information
Table 131. Kelun Pharmaceutical Description and Business Overview
Table 132. Kelun Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Kelun Pharmaceutical Enzalutamide Drugs Product
Table 134. Kelun Pharmaceutical Recent Developments/Updates
Table 135. Yichang Humanwell Pharmaceutical Company Information
Table 136. Yichang Humanwell Pharmaceutical Description and Business Overview
Table 137. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product
Table 139. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 140. Jiangsu Hansoh Pharmaceutical Company Information
Table 141. Jiangsu Hansoh Pharmaceutical Description and Business Overview
Table 142. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product
Table 144. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 145. PuraCap Pharmaceuticals Company Information
Table 146. PuraCap Pharmaceuticals Description and Business Overview
Table 147. PuraCap Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. PuraCap Pharmaceuticals Enzalutamide Drugs Product
Table 149. PuraCap Pharmaceuticals Recent Developments/Updates
Table 150. Shenyang Hongqi Pharmaceutical Company Information
Table 151. Shenyang Hongqi Pharmaceutical Description and Business Overview
Table 152. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product
Table 154. Shenyang Hongqi Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Enzalutamide Drugs Distributors List
Table 158. Enzalutamide Drugs Customers List
Table 159. Enzalutamide Drugs Market Trends
Table 160. Enzalutamide Drugs Market Drivers
Table 161. Enzalutamide Drugs Market Challenges
Table 162. Enzalutamide Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Enzalutamide Drugs
Figure 2. Global Enzalutamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enzalutamide Drugs Market Share by Type: 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Enzalutamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Enzalutamide Drugs Market Share by Application: 2023 & 2030
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Enzalutamide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Enzalutamide Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Enzalutamide Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Enzalutamide Drugs Average Price (US$/Unit) & (2019-2030)
Figure 15. Enzalutamide Drugs Report Years Considered
Figure 16. Enzalutamide Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Enzalutamide Drugs Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Enzalutamide Drugs Players: Market Share by Revenue in Enzalutamide Drugs in 2023
Figure 19. Enzalutamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Enzalutamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Enzalutamide Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Enzalutamide Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Enzalutamide Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Enzalutamide Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 42. Mexico Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Enzalutamide Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Enzalutamide Drugs by Type (2019-2030)
Figure 52. Global Revenue Market Share of Enzalutamide Drugs by Type (2019-2030)
Figure 53. Global Enzalutamide Drugs Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Enzalutamide Drugs by Application (2019-2030)
Figure 55. Global Revenue Market Share of Enzalutamide Drugs by Application (2019-2030)
Figure 56. Global Enzalutamide Drugs Price (US$/Unit) by Application (2019-2030)
Figure 57. Enzalutamide Drugs Value Chain
Figure 58. Enzalutamide Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Enzalutamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Enzalutamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Enzalutamide Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Enzalutamide Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Enzalutamide Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Enzalutamide Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Enzalutamide Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Enzalutamide Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Enzalutamide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enzalutamide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enzalutamide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Enzalutamide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enzalutamide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzalutamide Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enzalutamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Enzalutamide Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Enzalutamide Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Enzalutamide Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Enzalutamide Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Enzalutamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Enzalutamide Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Enzalutamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Enzalutamide Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Enzalutamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Enzalutamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Enzalutamide Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Enzalutamide Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Enzalutamide Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Enzalutamide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Enzalutamide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Enzalutamide Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Enzalutamide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Enzalutamide Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Enzalutamide Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Enzalutamide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Enzalutamide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Enzalutamide Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Enzalutamide Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Enzalutamide Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Enzalutamide Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Enzalutamide Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Enzalutamide Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Enzalutamide Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Enzalutamide Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Enzalutamide Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Enzalutamide Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Enzalutamide Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Enzalutamide Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Enzalutamide Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Enzalutamide Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Enzalutamide Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Enzalutamide Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Enzalutamide Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Enzalutamide Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Enzalutamide Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Enzalutamide Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Astellas Pharma Company Information
Table 71. Astellas Pharma Description and Business Overview
Table 72. Astellas Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Astellas Pharma Enzalutamide Drugs Product
Table 74. Astellas Pharma Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Enzalutamide Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Intas Pharmaceuticals Company Information
Table 81. Intas Pharmaceuticals Description and Business Overview
Table 82. Intas Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Intas Pharmaceuticals Enzalutamide Drugs Product
Table 84. Intas Pharmaceuticals Recent Developments/Updates
Table 85. Beacon pharma Company Information
Table 86. Beacon pharma Description and Business Overview
Table 87. Beacon pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Beacon pharma Enzalutamide Drugs Product
Table 89. Beacon pharma Recent Developments/Updates
Table 90. Aprazer Healthcare Pharma Company Information
Table 91. Aprazer Healthcare Pharma Description and Business Overview
Table 92. Aprazer Healthcare Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Aprazer Healthcare Pharma Enzalutamide Drugs Product
Table 94. Aprazer Healthcare Pharma Recent Developments/Updates
Table 95. Arechar Healthcare Company Information
Table 96. Arechar Healthcare Description and Business Overview
Table 97. Arechar Healthcare Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Arechar Healthcare Enzalutamide Drugs Product
Table 99. Arechar Healthcare Recent Developments/Updates
Table 100. Glenmark Pharma Company Information
Table 101. Glenmark Pharma Description and Business Overview
Table 102. Glenmark Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Glenmark Pharma Enzalutamide Drugs Product
Table 104. Glenmark Pharma Recent Developments/Updates
Table 105. Sun Pharma Company Information
Table 106. Sun Pharma Description and Business Overview
Table 107. Sun Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sun Pharma Enzalutamide Drugs Product
Table 109. Sun Pharma Recent Developments/Updates
Table 110. Zydus Company Information
Table 111. Zydus Description and Business Overview
Table 112. Zydus Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zydus Enzalutamide Drugs Product
Table 114. Zydus Recent Developments/Updates
Table 115. Abbott Laboratories Company Information
Table 116. Abbott Laboratories Description and Business Overview
Table 117. Abbott Laboratories Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Abbott Laboratories Enzalutamide Drugs Product
Table 119. Abbott Laboratories Recent Developments/Updates
Table 120. BDR Pharma Company Information
Table 121. BDR Pharma Description and Business Overview
Table 122. BDR Pharma Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. BDR Pharma Enzalutamide Drugs Product
Table 124. BDR Pharma Recent Developments/Updates
Table 125. Qilu Pharmaceutical Company Information
Table 126. Qilu Pharmaceutical Description and Business Overview
Table 127. Qilu Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Qilu Pharmaceutical Enzalutamide Drugs Product
Table 129. Qilu Pharmaceutical Recent Developments/Updates
Table 130. Kelun Pharmaceutical Company Information
Table 131. Kelun Pharmaceutical Description and Business Overview
Table 132. Kelun Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Kelun Pharmaceutical Enzalutamide Drugs Product
Table 134. Kelun Pharmaceutical Recent Developments/Updates
Table 135. Yichang Humanwell Pharmaceutical Company Information
Table 136. Yichang Humanwell Pharmaceutical Description and Business Overview
Table 137. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Yichang Humanwell Pharmaceutical Enzalutamide Drugs Product
Table 139. Yichang Humanwell Pharmaceutical Recent Developments/Updates
Table 140. Jiangsu Hansoh Pharmaceutical Company Information
Table 141. Jiangsu Hansoh Pharmaceutical Description and Business Overview
Table 142. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Jiangsu Hansoh Pharmaceutical Enzalutamide Drugs Product
Table 144. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 145. PuraCap Pharmaceuticals Company Information
Table 146. PuraCap Pharmaceuticals Description and Business Overview
Table 147. PuraCap Pharmaceuticals Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. PuraCap Pharmaceuticals Enzalutamide Drugs Product
Table 149. PuraCap Pharmaceuticals Recent Developments/Updates
Table 150. Shenyang Hongqi Pharmaceutical Company Information
Table 151. Shenyang Hongqi Pharmaceutical Description and Business Overview
Table 152. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Shenyang Hongqi Pharmaceutical Enzalutamide Drugs Product
Table 154. Shenyang Hongqi Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Enzalutamide Drugs Distributors List
Table 158. Enzalutamide Drugs Customers List
Table 159. Enzalutamide Drugs Market Trends
Table 160. Enzalutamide Drugs Market Drivers
Table 161. Enzalutamide Drugs Market Challenges
Table 162. Enzalutamide Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Enzalutamide Drugs
Figure 2. Global Enzalutamide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enzalutamide Drugs Market Share by Type: 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Enzalutamide Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Enzalutamide Drugs Market Share by Application: 2023 & 2030
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Enzalutamide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Enzalutamide Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Enzalutamide Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Enzalutamide Drugs Average Price (US$/Unit) & (2019-2030)
Figure 15. Enzalutamide Drugs Report Years Considered
Figure 16. Enzalutamide Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Enzalutamide Drugs Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Enzalutamide Drugs Players: Market Share by Revenue in Enzalutamide Drugs in 2023
Figure 19. Enzalutamide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Enzalutamide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Enzalutamide Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Enzalutamide Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Enzalutamide Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Enzalutamide Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 42. Mexico Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Enzalutamide Drugs Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Enzalutamide Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Enzalutamide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Enzalutamide Drugs by Type (2019-2030)
Figure 52. Global Revenue Market Share of Enzalutamide Drugs by Type (2019-2030)
Figure 53. Global Enzalutamide Drugs Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Enzalutamide Drugs by Application (2019-2030)
Figure 55. Global Revenue Market Share of Enzalutamide Drugs by Application (2019-2030)
Figure 56. Global Enzalutamide Drugs Price (US$/Unit) by Application (2019-2030)
Figure 57. Enzalutamide Drugs Value Chain
Figure 58. Enzalutamide Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232